发明名称 |
USE OF 3- (4-AMINO-1-OXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE FOR THE TREATMENT OF MANTLE CELL LYMPHOMAS |
摘要 |
The treatment, prevention or management of mantle cell lymphomas by administration of an immunomodulatory compound of the invention known as Revlimid<SUP>®</SUP> or lenalidomide are disclosed. The invention further relates to the use of this compound with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy for the claimed treatment. Pharmaceutical compositions and single unit dosage forms suitable for use in the invention are also disclosed. |
申请公布号 |
WO2008019065(A1) |
申请公布日期 |
2008.02.14 |
申请号 |
WO2007US17343 |
申请日期 |
2007.08.02 |
申请人 |
CELGENE CORPORATION;ZELDIS, JEROME, B. |
发明人 |
ZELDIS, JEROME, B. |
分类号 |
A61K31/454;A61K39/395;A61K45/06;A61P35/00 |
主分类号 |
A61K31/454 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|